Richmond Times-Dispatch

FDAOKs antibody drug Trump received for emergency use


U.S. health officials on Saturday agreed to allow emergency use of a second antibody drug to help the immune system fight COVID19, an experiment­al medicine that President Donald Trump was given when he was sickened last month.

The Food and Drug Administra­tion authorized use of the Regeneron Pharmaceut­icals Inc. drug to try to prevent hospitaliz­ation and worsening disease from developing in patients with mild to moderate symptoms.

Emergency authorizat­ion allows use of the drug to start while studies are continuing to establish safety and effectiven­ess. Early results suggest the drug may reduce COVID-19-related hospitaliz­ation or emergency room visits in patients at high risk for disease progressio­n, the FDA said.

Newspapers in English

Newspapers from United States